VA
VERA icon

Verdad Advisers’s Vera Therapeutics VERA Stock Holding History

Verdad Advisers’s Portfolio VERA Stock Details VERA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$410K Buy
+10,181
New +$439K 0.46% 78

Other funds holding VERA

ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
KCM
Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Verdad Advisers's VERA Position: Q1 2026 in Review

Verdad Advisers opened a new position in Vera Therapeutics (VERA) in Q1 2026: 10,181 shares worth $410K. The stake represents 0.46% of the portfolio and ranks #78 among its holdings.

229 funds tracked by Wall St. Rank hold VERA as of Q1 2026.

  • Verdad Advisers held 10,181 shares of Vera Therapeutics worth $410K as of Q1 2026.
  • Vera Therapeutics was a new Verdad Advisers position in Q1 2026.
  • Vera Therapeutics made up 0.46% of Verdad Advisers's portfolio in Q1 2026, its #78 holding.
  • 229 funds tracked by Wall St. Rank held Vera Therapeutics as of Q1 2026.

Based on Verdad Advisers's 13F filing for Q1 2026, filed 15 May 2026.